Research ArticleArticle
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience
Aladdin J. Mohammad, Rona M. Smith, Yok W. Chow, Afzal N. Chaudhry and David R.W. Jayne
The Journal of Rheumatology October 2015, 42 (10) 1906-1913; DOI: https://doi.org/10.3899/jrheum.141344
Aladdin J. Mohammad
From the Department of Renal Medicine, Addenbrooke’s Hospital, Cambridge,
UK; Department of Clinical Sciences, Rheumatology, Lund University, Lund,
Sweden; Department of Medicine, Hospital Pantai Ayer Keroh, Melaka,
Malaysia.
Rona M. Smith
Yok W. Chow
Afzal N. Chaudhry
REFERENCES
- 1.↵
- 2.↵
- Direskeneli H
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Dalghous AM,
- Freysdottir J,
- Fortune F
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- Zhang X,
- Tao Y,
- Chopra M,
- Ahn M,
- Marcus KL,
- Choudhary N,
- et al.
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- Dick AD,
- Meyer P,
- James T,
- Forrester JV,
- Hale G,
- Waldmann H,
- et al.
- 21.↵
- Lockwood CM,
- Hale G,
- Waldman H,
- Jayne DR
- 22.↵
- Sfikakis PP,
- Markomichelakis N,
- Alpsoy E,
- Assaad-Khalil S,
- Bodaghi B,
- Gul A,
- et al.
- 23.↵
- Lindstedt EW,
- Baarsma GS,
- Kuijpers RW,
- van Hagen PM
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- Walsh M,
- Chaudhry A,
- Jayne D
- 29.↵
- Azzopardi L,
- Thompson SA,
- Harding KE,
- Cossburn M,
- Robertson N,
- Compston A,
- et al.
- 30.↵
- 31.↵
- National Health Service
- 32.↵
In this issue
The Journal of Rheumatology
Vol. 42, Issue 10
1 Oct 2015
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience
Aladdin J. Mohammad, Rona M. Smith, Yok W. Chow, Afzal N. Chaudhry, David R.W. Jayne
The Journal of Rheumatology Oct 2015, 42 (10) 1906-1913; DOI: 10.3899/jrheum.141344